Rheumatology Resources

City-Wide Rheumatology Rounds

April 19, 2024 | Local Research, World-wide Impact. Celebrating our Research Community: PART 2

8:30am to 12:00pm EST

Location: 89 Chestnut Street, 2nd Floor - Giovanni Room
Toronto, ON M5G 1R1 

8:00       Registration & Light Breakfast     
8:30       Program begins
12:00     Program Concludes

Speakers:
TBC

January 19, 2024 | Corticosteroids in Rheumatoid Arthritis – Current Knowledge and Suggested Project to Address Existing Gaps

Registration
8:30am to 12:30pm EST

Location: 89 Chestnut Street, 2nd Floor - Giovanni Room
Toronto, ON M5G 1R1 

8:00am       Registration & Light Breakfast     
8:30am       Program begins
12:30pm     Program Concludes

Speakers:
Lihi Eder
Maarten Boers
Tim Kwok

December 8, 2023 | Bone: not as simple as we thought.

Registration
8:30am to 12:00pm EST

Location: 89 Chestnut Street, 2nd Floor - Giovanni Room
Toronto, ON M5G 1R1 

8:00am       Registration & Light Breakfast     
8:30am       Program begins
11:45am     Program Concludes & Lunch will be available 

Speakers:
Heather McDonald-Blumer
Robert Rottapel
Lianne Tile
Sandra Kim

October 20, 2023 | Axial Spondyloarthritis: Past Breakthroughs, Current Advances

8:00am to 12:00pm EST

Location: 89 Chestnut Street, 2nd Floor - Giovanni Room
Toronto, ON M5G 1R1 

Speakers:
Denis Poddubnyy
Sinead Maguire 
Zoya Qaiyum 
Aki Nakamura
Laura Passalent
Zeynep Baskurt 
Archita Srinath
Fataneh Tavasolian

April 21, 2023 | Celebrating our Research Community: PART 1

Event Registration
8:00am to 11:45am EST, In-Person

Location: 89 Chestnut St, Toronto, ON M5G 1R1 (Giovanni Room)

Highlighted Programs
PsA Program
Transition and QI 
Lupus Program
 

Annual Ogryzlo Research Day

June 20, 2023 | Keynote Speaker: Brad H. Rovin, MD, FASN, FACP

“We finally have approved drugs for Lupus Nephritis: So now what?”

Dr. Brad H. Rovin is the Lee A. Hebert Professor of Nephrology. Dr. Rovin received his Bachelor of Science in Chemical Engineering from Northwestern University in Evanston Illinois and his Doctor of Medicine from the University of Illinois Medical School in Chicago, Illinois. He completed a residency in Internal Medicine at Barnes Hospital in St. Louis Missouri, and a Fellowship in Nephrology at Washington University School of Medicine, St.  Louis. He joined the College of Medicine Faculty in 1990, became Director of the Division of Nephrology in 2004,  and served as Vice Chairman of Medicine for Research from 2009‐2019. In 2019 he became the Medical Director of  the Ohio State University Clinical Research Management Institute.  

Dr. Rovin has had several leadership roles in the American Society of Nephrology, including running the Glomerular  Diseases Pre‐Course and Co‐Editing NephSAP‐Glomerular Diseases, a continuing education program of the Society. Most recently he was appointed Deputy Editor of Kidney International, the flagship journal of the International  Society of Nephrology. He also is Co‐Chair for glomerular disease guideline development for the Kidney Disease  Improving Global Outcomes effort.  

Dr. Rovin studies the immunopathogenesis of glomerular and autoimmune diseases. He is heavily involved in  clinical trial development and design for investigator‐initiated and industry‐sponsored trials. He is a founding  member of NephroNet, a grass‐roots nephrology community clinical trial organization, and the Lupus Nephritis  Clinical Trials Network. He is and has been the Principal Investigator on several trials of novel therapeutics for glomerular diseases. 

June 21, 2022 | Keynote Speaker: Peter A. Merkel, MD, MPH

“Update on the Treatment of ANCA-Associated Vasculitis”

Dr. Merkel is the Chief of Rheumatology and a Professor of Medicine and Epidemiology at the University of Pennsylvania. Dr. Merkel is an internationally recognized research and clinical expert in vasculitis and scleroderma and is an author on over 400 scientific publications. He is the Principal Investigator of the NIH-Sponsored Vasculitis Clinical Research Consortium (VCRC), a leading international research infrastructure for vasculitis clinical investigation. Dr. Merkel’s research focuses on clinical trial design and conduct, outcome measure development, clinical epidemiology, genetic epidemiology, and biomarker discovery.

Dr. Merkel received his MD from Yale University, his MPH from Harvard University, completed his residency training at the Hospital of the University of Pennsylvania and his fellowship at the Massachusetts General Hospital/Harvard Medical School. Dr. Merkel has received the majority of his research support from the National Institutes of Health, the US Food and Drug Administration, the Patient-Centered Outcomes Research Institute, with additional funding from industry sources and private foundations.

Bombardier Research Rounds

April 8, 2024 | TBC 

8:00am to 9:00am EST
Virtual

Speaker: Laura Passalent

March 4, 2024 | Difficult-to-treat Psoriatic Arthritis

8:00am to 9:00am EST
Virtual

Speaker:  Dr. Andre Ribeiro

Andre Ribeiro, MD MSc, is a Clinical Research Fellow at the Psoriatic Arthritis and Musculoskeletal Ultrasound Program at Women's College Hospital. He completed his medical education and a Master's in Medical Sciences at Universidade Federal do Rio Grande do Sul, Brazil, and his Internal Medicine and Rheumatology training at Hospital de Clínicas de Porto Alegre. Ribeiro focuses on psoriatic arthritis research, is an active Young-GRAPPA member, participating in multiple projects, and was recently elected Chair of Young-GRAPPA.

February 5, 2024 | Evaluating the Role of Interdisciplinary Models of Rheumatology Care on Advancing the Quintuple Aims of Health Care

8:00am to 9:00am EST
Virtual

Speaker: Nicolas S. Bodmer

Nicolas S. Bodmer is a PhD student in the Clinical Epidemiology and Health Care Research program at the Institute of Health Policy, Management and Evaluation (IHPME). He graduated from medical school at the University of Zurich (Switzerland) and has been working in a med-tech and research company for over 10 years. Nicolas Bodmer’s research focuses on evidence synthesis, development of digital health innovations and evaluation of novel models of care.

January 8, 2024 | Calcium Pyrophosphate Deposition Disease

8:00am to 9:00am EST
Virtual

Speaker: Dr. Tuhina Neogi

Dr. Tuhina Neogi is Professor of Medicine and of Epidemiology at Boston University Schools of Medicine and of Public Health, the endowed Alan S. Cohen Professor of Rheumatology, and Chief of Rheumatology at Boston Medical Center. She completed her medical school, internal medicine, and rheumatology training at the University of Toronto. As a rheumatologist and PhD-trained epidemiologist, her research focuses on osteoarthritis and gout, with a particular focus on pain mechanisms.

December 4, 2023 | Updating the Systemic Lupus Erythematosus Core Outcome Set

8:00am to 9:00am EST
Virtual

Speaker: Wils Nielsen

Wils Nielsen is a PhD candidate with the Institute of Medical Science at UofT, in the Toronto Lupus Program at UHN since 2021, with a research focus on measurement science and Systemic Lupus Erythematosus. Wils is also the fellow for the OMERACT (Outcome Measures in Rheumatology) Systemic Lupus Erythematosus Working Group.

Residency Program

Program Contacts

Dr. Dana Jerome, Program Director
dana.jerome@wchospital.ca 

Melanie Moscovitch, Program Coordinator
rheumatology@utoronto.ca

Chief Medical Resident
rheumchief.utoronto@gmail.com